| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |